Literature DB >> 2692642

Evidence for the 5-HT hypothesis of suicide. A review of post-mortem studies.

J J Mann1, V Arango, P M Marzuk, S Theccanat, D J Reis.   

Abstract

Although suicide was traditionally considered an extreme response to stress, with the most frequent stress being depressive illness, severity of depression does not distinguish those who commit suicide from non-suicide attempters. A biological role involving the serotonergic system, possibly associated with a genetic risk factor, has been postulated. Low levels of 5-HT and 5-HIAA have been found in post-mortem examinations of brain-stem tissues of suicide victims (levels in cortical tissue were generally normal). An increased number of 5-HT2 receptors was found in the pre-frontal cortex of suicide victims, such upregulation having been demonstrated in induced 5-HT deficiency states; 5-HT1A receptors were also increased. Receptor populations may be altered by chronic psychotropic medication; e.g. 5-HT2 downregulation occurs following administration of antidepressants. There is some indication that the adrenergic system may be involved as well, but this will require further study. Antidepressant drugs may be effective in preventing suicide in patients with non-depressive syndromes who exhibit suicidal behaviour.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2692642

Source DB:  PubMed          Journal:  Br J Psychiatry Suppl        ISSN: 0960-5371


  28 in total

Review 1.  Conceptual foundations of the UCSD Statin Study: a randomized controlled trial assessing the impact of statins on cognition, behavior, and biochemistry.

Authors:  Beatrice Alexandra Golomb; Michael H Criqui; Halbert White; Joel E Dimsdale
Journal:  Arch Intern Med       Date:  2004-01-26

Review 2.  Neuroendocrine effects on mood.

Authors:  Margaret G Spinelli
Journal:  Rev Endocr Metab Disord       Date:  2005-05       Impact factor: 6.514

3.  Platelet imipramine binding in intensive care unit suicidal patients.

Authors:  D De Leo; A Caneva; D Marazziti; L Conti
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1991       Impact factor: 5.270

4.  Lower 3H-paroxetine binding in cerebral cortex of suicide victims is partly due to fewer high affinity, non-transporter sites.

Authors:  J J Mann; R A Henteleff; T F Lagattuta; J A Perper; S Li; V Arango
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

5.  Plasticity of presynaptic and postsynaptic serotonin 1A receptors in an animal model of epilepsy-associated depression.

Authors:  Eduardo A Pineda; Julie G Hensler; Raman Sankar; Don Shin; Teresa F Burke; Andréy M Mazarati
Journal:  Neuropsychopharmacology       Date:  2011-02-23       Impact factor: 7.853

6.  Chronic non-invasive corticosterone administration abolishes the diurnal pattern of tph2 expression.

Authors:  Nina C Donner; Christian D Montoya; Jodi L Lukkes; Christopher A Lowry
Journal:  Psychoneuroendocrinology       Date:  2011-09-15       Impact factor: 4.905

7.  Comorbidity between epilepsy and depression: role of hippocampal interleukin-1beta.

Authors:  Andrey M Mazarati; Eduardo Pineda; Don Shin; Delia Tio; Anna N Taylor; Raman Sankar
Journal:  Neurobiol Dis       Date:  2009-11-10       Impact factor: 5.996

8.  Omega-3 fatty acid deficiency during perinatal development increases serotonin turnover in the prefrontal cortex and decreases midbrain tryptophan hydroxylase-2 expression in adult female rats: dissociation from estrogenic effects.

Authors:  Robert K McNamara; Jessica Able; Yanhong Liu; Ronald Jandacek; Therese Rider; Patrick Tso; Jack W Lipton
Journal:  J Psychiatr Res       Date:  2008-11-04       Impact factor: 4.791

Review 9.  The serotonergic system in mood disorders and suicidal behaviour.

Authors:  J John Mann
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-02-25       Impact factor: 6.237

10.  A preliminary study of cytokines in suicidal and nonsuicidal adolescents with major depression.

Authors:  Vilma Gabbay; Rachel G Klein; Leah E Guttman; James S Babb; Carmen M Alonso; Melissa Nishawala; Yisrael Katz; Marta R Gaite; Charles J Gonzalez
Journal:  J Child Adolesc Psychopharmacol       Date:  2009-08       Impact factor: 2.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.